WST vs NVDA: Which Stock is Better?

Side-by-side comparison of West Pharmaceutical Services Inc and NVIDIA Corporation in 2026

Comparison Updated:

WST

West Pharmaceutical Services Inc

$271.83

NVDA

NVIDIA Corporation

$185.81

Key Metrics Comparison

MetricWSTNVDAWinner
Market Cap$19.63B$4.50TNVDA
P/E Ratio40.4945.89WST
EPS (TTM)$6.74$4.03WST
Revenue Growth0.1%0.6%NVDA
Gross Margin35.6%70.1%NVDA

Analyze WST

Full quant analysis

Analyze NVDA

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is WST or NVDA a better investment?

Comparing WST and NVDA: West Pharmaceutical Services Inc has a market cap of $19.63B while NVIDIA Corporation has $4.50T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between WST and NVDA?

WST (West Pharmaceutical Services Inc) and NVDA (NVIDIA Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: WST or NVDA?

Based on P/E ratios, WST trades at a lower multiple (40.5x vs 45.9x).

Which is growing faster: WST or NVDA?

NVDA has higher revenue growth at 0.6% vs 0.1% for WST.

Which company is more profitable: WST or NVDA?

NVIDIA Corporation (NVDA) has higher gross margins at 70.1% compared to 35.6% for WST.

Which is the larger company: WST or NVDA?

NVIDIA Corporation (NVDA) is larger with a market cap of $4.50T compared to $19.63B for WST.

Should I buy WST or NVDA in 2026?

Both WST and NVDA have investment merit. WST trades at $271.83 while NVDA trades at $185.81. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between WST and NVDA stock?

Key differences: Market Cap ($19.63B vs $4.50T), P/E Ratio (40.5x vs 45.9x), Revenue Growth (0.1% vs 0.6%), Gross Margin (35.6% vs 70.1%).

Popular Stock Comparisons